Skip to main content
AmigoFish

Ep. 144: “Atypical T Cell Lineages” Featuring Dr. Dan Littman

From The Immunology Podcast · · 1 hr 22 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

http://www.immunologypodcast.com/wp-content/uploads/2026/11/IP-144-Thumbnail.jpg

Guest:

Dr. Dan Littman is a Professor at the NYU Grossman School of Medicine. He discusses how his lab investigates the molecular mechanisms that regulate T cell development and differentiation, including the role of RORγt in shaping immune cell identity and function. He also explores the discovery of unconventional antigen-presenting cells involved in immune tolerance, how the gut microbiome influences T cell responses and cancer immunotherapy, and the potential of emerging technologies to uncover the complex interactions between microbes and the immune system.

Featured Products and Resources:

- Scale up your cell isolation and process large-volume samples with the new Easy 250 EasySep Magnet. (http://www.stemcell.com/easy250magnet)

- Stay current with the latest news, research, policy, and jobs in the immunology community with Immune Regulations News. (http://www.ImmuneRegulationNews.com)

The Immunology Science Round Up

Sugar Disrupts the Microbiome (https://www.nature.com/articles/s41586-026-11077-3) – High sugar intake during antibiotic treatment worsens gut microbiome disruption and promotes Enterococcus expansion.

Diet Shapes Immunotherapy Toxicity (https://www.cell.com/cell/abstract/S0092-8674(26)01202-X) – Diet and gut microbiota influence immunotherapy side effects, revealing potential ways to reduce inflammation.

Tregs Support Intestinal Recovery (https://www.nature.com/articles/s41467-026-78796-z)– Intestinal epithelial NF-κB signaling recruits regulatory T cells to promote inflammation resolution and tissue repair.

PPARδ Boosts Anti-Tumor Immunity (https://www.nature.com/articles/s41590-026-02685-2) – Activating PPARδ enhances T cell metabolism and anti-tumor activity, improving immunotherapy responses in preclinical models.

Image courtesy of Dr. Dan Littman

Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe

Back to The Immunology Podcast · Report a problem